BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Xing QQ, Tu JK, Tang WB, Yuan XN, Xie YY, Wang W, Peng ZZ, Huang L, Xu H, Qin J, Xiao XC, Tao LJ, Yuan QJ. Involvement of hydrogen sulfide in the progression of renal fibrosis. Chin Med J (Engl) 2019;132:2872-80. [PMID: 31856060 DOI: 10.1097/CM9.0000000000000537] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 HaoShang, Jia X, Liu H, Zhang X, Shao Y. A comprehensive review of emodin in fibrosis treatment. Fitoterapia 2022;165:105358. [PMID: 36436587 DOI: 10.1016/j.fitote.2022.105358] [Reference Citation Analysis]
2 Peng Q, Li Y, Shang J, Huang H, Zhang Y, Ding Y, Liang Y, Xie Z, Chen C. Effects of Genistein on Common Kidney Diseases. Nutrients 2022;14:3768. [DOI: 10.3390/nu14183768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Wang SJ, Qiu ZZ, Chen FW, Mao AL, Bai JC, Hong YJ, Zhang ZP, Zhu WA, Zhang ZW, Zhou H. Bone marrow mesenchymal stem cell-derived extracellular vesicles containing miR-181d protect rats against renal fibrosis by inhibiting KLF6 and the NF-κB signaling pathway. Cell Death Dis 2022;13:535. [PMID: 35672285 DOI: 10.1038/s41419-022-04875-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi N, Wang Z, Zhu H, Liu W, Zhao M, Jiang X, Zhao J, Ren C, Zhang Y, Luo L. Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases. Immunol Res 2022. [PMID: 35147920 DOI: 10.1007/s12026-022-09267-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Luo R, Wang T, Zhuo S, Guo X, Ma D. Excessive hydrogen sulfide causes lung and brain tissue damage by promoting PARP1/Bax and C9 and inhibiting LAMB1. Apoptosis 2022. [PMID: 35119561 DOI: 10.1007/s10495-021-01705-w] [Reference Citation Analysis]
6 Kaziród K, Myszka M, Dulak J, Łoboda A. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. Cell Mol Life Sci 2022;79:608. [PMID: 36441348 DOI: 10.1007/s00018-022-04636-0] [Reference Citation Analysis]
7 Zhang Y, Gong W, Xu M, Zhang S, Shen J, Zhu M, Wang Y, Chen Y, Shi J, Meng G. Necroptosis Inhibition by Hydrogen Sulfide Alleviated Hypoxia-Induced Cardiac Fibroblasts Proliferation via Sirtuin 3. Int J Mol Sci 2021;22:11893. [PMID: 34769322 DOI: 10.3390/ijms222111893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Chirindoth SS, Cancarevic I. Role of Hydrogen Sulfide in the Treatment of Fibrosis. Cureus 2021;13:e18088. [PMID: 34692303 DOI: 10.7759/cureus.18088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Yang F, Deng L, Li J, Chen M, Liu Y, Hu Y, Zhong W. Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ-Smad Signaling Pathway. Drug Des Devel Ther 2020;14:3567-75. [PMID: 32943844 DOI: 10.2147/DDDT.S245847] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Pieretti JC, Junho CVC, Carneiro-Ramos MS, Seabra AB. H2S- and NO-releasing gasotransmitter platform: A crosstalk signaling pathway in the treatment of acute kidney injury. Pharmacol Res 2020;161:105121. [PMID: 32798649 DOI: 10.1016/j.phrs.2020.105121] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]